Watch Dr. Jonna Mazet’s Keynote Here!
“The power of working across sectors: Using a One Health approach to identify and mitigate emerging health threats”
Jonna Mazet, DVM, MPVM, PhD, is Professor of Epidemiology and Disease Ecology in the UC Davis One Health Institute and UC San Francisco Institute for Global Health Sciences. She employs the One Health approach to understand and mitigate disease transmission among wildlife, domestic animals, and people, considering the ecological drivers of disease emergence. She is the Co-Director of USAID’s One Health Workforce – Next Generation, an educational strengthening project empowering professionals in Africa and Southeast Asia to address complex health threats. She is a member of the US National Academy of Medicine and serves on the NASEM’s Forum on Microbial Threats and One Health Action Collaborative. She was appointed to the National Academies Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, which was created to assist the federal government with critical science and policy issues related to the COVID-19 crisis and other emerging health threats.
Watch Dr. Stanley Perlman’s Keynote Here!
“COVID-19: Immune Responses and Animal Models”
Dr. Perlman received his Ph.D. in Biophysics from M.I.T., Cambridge, Massachusetts and his M.D. from the University of Miami, Miami, Florida. He was trained in Pediatrics and Pediatric Infectious Diseases at Boston Children’s Hospital, Boston, Massachusetts. His current research efforts are focused on coronavirus pathogenesis, including virusinduced demyelination and the Severe Acute Respiratory Syndrome (SARS), the Middle East Respiratory Syndrome (MERS) and COVID-19. His laboratory has developed several novel animal models useful for studying pathogenesis and evaluating vaccines and anti-viral therapies. His studies are directed at understanding why aged patients and mice developed more severe disease than younger individuals after infection with SARS-CoV or SARS-CoV-2 and also on why there is a male predominance in patients with more severe disease after infection with SARSCoV, MERS-CoV or SARS-CoV-2. He and his colleagues demonstrated that transduction of mice with an adenovirus expressing the human receptor for MERS-CoV, DPP4, rendered them sensitive to infection, providing the first rodent model useful for studying MERS. Similar approaches have been used to develop a mouse model for COVID-19. He has also developed models for the loss of sense of smell (anosmia) observed in patients with COVID-19.
Watch Dr. Jean Tsao’s Keynote Here!
We are pleased to announce our keynote speaker will be Dr. Jean Tsao!
Dr. Tsao’s keynote address was held on Friday, March 27th. The keynote address is open to the general public.
Title: Predicting the Effects of Climate Change and Emergence of Ticks and Tick Borne Disease: Why Understanding Tick Biology and Ecology Matters
With more than 300,000 human cases estimated a year, Lyme disease is the leading vector-borne disease in the United States. Over the last fifteen years, I have had the opportunity to work in different regions where Lyme disease is hyperendemic, invading, or predominantly cryptic. Studying the blacklegged tick and Lyme disease pathogen across such varied habitats and in different stages of establishment has given me a great appreciation for the ecological “flexibility” of the tick and bacterium and the complex roles that biotic and abiotic factors play in influencing disease risk. More knowledge about the ecology and evolution of ticks and tick-borne pathogens clearly is needed to predict and mitigate disease risk in the future. Additionally, the biologically and socially complex nature of Lyme disease requires improved communication and collaboration among many disciplines, health practitioners, patients, and the public. As such, the Lyme disease system provides an apt opportunity to conduct research in the frameworks of One Health and Conservation Medicine. My lab works closely with colleagues in public health at both the state and federal levels. I am a member of the CDC-funded Midwestern Center of Excellence for Vector Biology. Besides Ixodes scapularis and the Lyme disease pathogen, my lab also studies other emerging ticks and tick-borne pathogens.
For more information on the 2020 GPEID Conference click on the main GPEID Conference tab.